Basic research on thrombomodulin
نویسندگان
چکیده
منابع مشابه
A basic scientist’s reflections on research funding
Scientists are among the most enthusiastic people when it comes to talking about their work. Despite this, it seems that it is the funding system that Canadian scientists most often discuss these days, and not their findings and new ideas. Needless to say, research can only exist with good and secure funding, but when obtaining funding becomes a dominant part of investigators’ activity, the sys...
متن کاملBasic research conducted on alloplant biomaterials.
PURPOSE To reduce antigenicity of allografts and stimulate their replacement by natural recipient tissues. METHODS Experimental allotransplantation of different tissues (fascias, tendons, derma, fat, etc.) with histological, histochemical, electron microscopical, electron histochemical examination 3, 5, 7, 14, 21, 30, 60, 120, 180 and 360 days postoperatively. RESULTS Allografts of differen...
متن کاملPART I. BASIC RESEARCH Introduction to Basic Research
Since Stephen Paget’s “seed-and-soil” theory was published in 1889, a wealth of research has focused on the cascade of events involved in the spread of cancer cells from the primary tumor to secondary organs. As Paget highlighted, in addition to the intrinsic properties of metastatic cancer cells, features of the microenvironment in target organs of metastasis are also critical for successful t...
متن کاملBasic and translational research
1Division of Rheumatology and Immunogenetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA 2Department of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA 3Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA 4Department of Medicine/ Rheumatolog...
متن کاملBasic and translational research
Weinblatt ME, Bingham CO, Mendelsohn AM, et al. Ann Rheum Dis (2012). doi:10.1136/annrheumdis-2012-201411 1 of 9 and anti-TNF-experienced4 patients with RA when administered monthly via subcutaneous injection. Intravenous administration of golimumab every 12 weeks (q12 weeks) was previously assessed in a phase 3 trial in patients with RA, with persistent disease despite MTX therapy.5 While the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Thrombosis and Hemostasis
سال: 2014
ISSN: 0915-7441,1880-8808
DOI: 10.2491/jjsth.25.55